Eagle Pharmaceuticals
EGRX
#10601
Rank
A$4.75 M
Marketcap
A$0.36
Share price
0.00%
Change (1 day)
-76.83%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: A$4.75 Million

As of April 2026 Eagle Pharmaceuticals has a market cap of A$4.75 Million. This makes Eagle Pharmaceuticals the world's 10601th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$4.75 M-45.44%
2025A$8.7 M-24.02%
2024A$11.45 M-88.51%
2023A$99.69 M-82.17%
2022A$0.55 B-38.36%
2021A$0.90 B14.93%
2020A$0.78 B-32.53%
2019A$1.16 B46.98%
2018A$0.79 B-22.06%
2017A$1.02 B-40.06%
2016A$1.70 B-10.5%
2015A$1.90 B615.91%
2014A$0.26 B

End of Day market cap according to different sources

On Mar 31st, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
A$4.75 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$849.56 B 17,884,824.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$432.91 B 9,113,465.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$1.233 T 25,971,701.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$275.01 B 5,789,482.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$182.00 B 3,831,504.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$162.86 B 3,428,422.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$50.87 B 1,070,929.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel